Literature DB >> 17539941

A comparative study of chronic inflammatory demyelinating polyradiculoneuropathy with and without diabetes mellitus.

J Kalita1, U K Misra, R K Yadav.   

Abstract

Diabetes mellitus (DM) is occasionally associated with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) raising the question of coexistence or etiological link. The study compares, neurophysiological and outcome of CIDP patients with and without DM. Consecutive CIDP patients were subjected to detailed clinical evaluation, haematology, serum chemistry, vasculitis profile, paraproteins, myeloma screening and cerebrospinal fluid (CSF) examination. Electrodiagnostic (EDx) tests included motor and sensory conduction and F-wave studies. The patients were treated with oral prednisolone 1 mg/kg/day with or without azathioprine 1-2 mg/kg and followed up for 6 months. The clinical and EDx finding in CIDP with and without DM were compared. Thirty-five CIDP patients were included and nine had DM. CIDP with diabetes (CIDP-D) had higher frequency of autonomic dysfunction. In CIDP-D, motor (38.9% vs. 16.7%) and sensory (40.7% vs. 14.1%) nerve conductions were more frequently unrecordable or had reduced compound muscle action potential (CMAP) amplitude. F-waves were also more frequently unrecordable in CIDP-D (28.8% vs. 12.8%) compared with idiopathic CIDP (I-CIDP). The degree of conduction block was more in I-CIDP. At 6-month follow up, I-CIDP patients improved better than CIDP-D. CIDP-D patients present with higher frequency of autonomic dysfunction, electrophysiological evidences of associated axonal loss and had a poorer outcome at 6 months compared with I-CIDP.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17539941     DOI: 10.1111/j.1468-1331.2007.01798.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  5 in total

1.  [Chronic paraneoplastic inflammatory demyelinating polyradiculoneuritis secondary to nasal natural killer lymphoma].

Authors:  Selim Jennane; Nawal Hasnaoui; Mahtat El Mehdi; Hicham El Maaroufi; Nezha Messaoudi; Mohamed Mikdame; Kamal Doghmi
Journal:  Pan Afr Med J       Date:  2020-08-18

2.  Chronic inflammatory demyelinating polyneuropathy.

Authors:  Mazen M Dimachkie; Richard J Barohn
Journal:  Curr Treat Options Neurol       Date:  2013-06       Impact factor: 3.598

Review 3.  Chronic inflammatory demyelinating polyradiculoneuropathy: from bench to bedside.

Authors:  Amanda C Peltier; Peter D Donofrio
Journal:  Semin Neurol       Date:  2012-11-01       Impact factor: 3.420

Review 4.  The dilemma of diabetes in chronic inflammatory demyelinating polyneuropathy.

Authors:  Vera Bril; Christopher M Blanchette; Joshua M Noone; M Chris Runken; Deborah Gelinas; James W Russell
Journal:  J Diabetes Complications       Date:  2016-05-10       Impact factor: 2.852

5.  Randomized, controlled crossover study of IVIg for demyelinating polyneuropathy and diabetes.

Authors:  Ari Breiner; Carolina Barnett Tapia; Leif Erik Lovblom; Bruce A Perkins; Hans D Katzberg; Vera Bril
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2019-07-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.